by rss feed | Sep 13, 2026 | IPS cells, News Feeds, Reprogramming, weekly reads
Do you buy the idea of using in vivo reprogramming to fight aging? How about to treat certain diseases? The stream of research pubs and news articles continues to grow. Before we jump into weekly reads including on reprogramming applications, on the 20th anniversary...
by rss feed | Sep 6, 2026 | GHK-Cu, News Feeds, Peptides, weekly reads
Anyone out there use a peptide cream? You might not even know it. I just saw by accident that one of the family uses a shampoo that says “peptides” on it. If you search on Amazon for “peptide cream” you get about an infinite number of...
by rss feed | Aug 30, 2026 | aging clocks, anti-aging, News Feeds, weekly reads
Depending on who you ask, aging clocks might be the best thing since sliced bread or still relatively imprecise tools that aren’t ready for prime time use for healthcare of any kind. I fall somewhere in the middle. These clocks are getting better and they...
by rss feed | Aug 23, 2026 | FDA Commissioner, News Feeds, weekly reads
The question of the week might be: who is Heidi Overton? I’ve been wondering who the new FDA commissioner might be for months. Marty Makary, Vinay Prasad, and Tracy Hoeg all left in the spring. There’s a big leadership vacuum at the agency. FDA...
by rss feed | Aug 9, 2026 | China gene therapy death, News Feeds, weekly reads
Perinatal tissue and cells have many potential applications. While I’ve mainly focused on placental, umbilical, and amniotic cell products in this area, some potential uses don’t require living cells. As with just about everything, you need good data to...
by rss feed | Aug 2, 2026 | Dynamic Stem Cell Therapy, News Feeds, weekly reads
How well do FDA warning and untitled letters address what the agency sees as noncompliant activities by unproven stem cell clinics and supplier firms? One might think these letters work well given the implicit threat that not complying with them could lead to more...
